Previous Article | Next Article ![]()
Journal of Bacteriology, July 2007, p. 5082-5089, Vol. 189, No. 14
0021-9193/07/$08.00+0 doi:10.1128/JB.00431-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Dean A. Russell,
Xiaoxiao Chen, and
Wim G. Meijer*
School of Biomolecular and Biomedical Science and Conway Institute, University College Dublin, Dublin 4, Ireland
Received 23 March 2007/ Accepted 7 May 2007
|
|
|---|
|
|
|---|
All R. equi strains isolated from foals harbor an 81-kb plasmid that has been shown to be essential for intracellular replication and virulence (10, 35, 36). This virulence plasmid contains a region of 27.5 kb that is characterized by a lower G+C content than the remainder of the virulence plasmid and the R. equi genome, indicating that it probably was acquired via lateral gene transfer (33). It was proposed that this region represents a pathogenicity island, a hypothesis that was lent credence by the fact that the transcription of genes located within it is upregulated following phagocytosis of R. equi (25, 33). Among these is a group of genes encoding a family of small proteins, one of which, virulence-associated protein A (VapA), has been shown to be a virulence factor (14).
Transcriptional regulation of pathogenicity island genes is subject to at least six different environmental parameters, including temperature and pH (3, 25, 32, 34). In contrast to this apparent regulatory complexity, only two genes encoding transcriptional regulators, located in a five-cistron operon (the virR operon, containing virR, orf5, vapH, orf7, and orf8), have been identified in the pathogenicity island (28, 33). It therefore is likely that regulators encoded by the R. equi genome play an important role in controlling the expression of pathogenicity island genes. This may be accomplished, at least in part, through controlling the expression levels of the two transcriptional regulators within the pathogenicity island. The virR gene encodes a LysR-type transcriptional regulator (LTTR) that is required for transcription of the vapA gene (28). The orf8 gene encodes a response regulator; interestingly, a cognate sensor kinase protein is not encoded on the virulence plasmid (33). Disruption of either gene attenuates R. equi, demonstrating their importance in controlling virulence (26). A recent report describing a low level of constitutive transcription of the virR gene while the transcript levels of the four downstream genes responded to changes in growth conditions (25) appeared to contradict our previous finding that the five genes constitute an operon (28). Considering the importance of the virR operon in controlling the virulence of R. equi, this apparent paradox was examined further. This paper reports that the observed difference in regulation of the virR operon genes is not due to differential mRNA stability of the virR operon transcript but to the presence of a regulated promoter within the virR gene driving transcription of orf5, vapH, orf7, and orf8.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids used in this study
|
(Bethesda Research Laboratories) and E. coli BL21(DE3)pLysE (Novagen) were used for general cloning procedures and for expression of virR-his, respectively. Bacterial strains were grown in Luria-Bertani (LB) broth (29). Growth of R. equi at 37°C and pH 6.5 (inducing conditions) was used to induce virulence plasmid gene expression, whereas these genes were transcribed at low levels following growth at 30°C and pH 8.0 (noninducing conditions). Where appropriate, the following supplements were added: kanamycin, 50 µg ml1 (E. coli) or 200 µg ml1 (R. equi); ampicillin, 50 µg ml1; apramycin, 30 µg ml1 (E. coli) or 80 µg ml1 (R. equi); chloramphenicol, 30 µg ml1; 5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside (X-Gal), 20 µg ml1; isopropyl-ß-D-thiogalactopyranoside (IPTG), 0.1 mM. For solid medium, agar was added at 1.5% (wt/vol). DNA manipulations. Chromosomal DNA was isolated as described previously (28). Plasmid DNA was isolated via the alkaline lysis method of Birnboim and Doly (5) or by using a Wizard Plus SV miniprep kit as described by the manufacturer (Promega). DNA fragments were isolated from agarose gels by using a Genelute DNA purification kit as described by the manufacturer (Sigma-Aldrich). PCR was carried out using Taq DNA polymerase (Promega) or Deep Vent DNA polymerase (New England Biolabs) as described by the manufacturer. Other DNA manipulations were done in accordance with standard protocols (29).
Plasmid construction. A region located on plasmid pJOE814.2 containing two transcriptional terminators and a xylE gene was amplified with Deep Vent DNA polymerase, using primers XylF and XylR. This 1,424-bp fragment was cloned into DraI-digested pREV5 to make pREV81. The xylE gene was subsequently excised by digesting pREV81 with ClaI, followed by religation of the 4,948-bp fragment, resulting in pREV6.
A series of DNA fragments serially shortened from the 5' end was constructed by PCR with the oligonucleotide BCMRev in conjunction with either ORF3PEX2, VirRT1, or 004F, using pBlueRegP1 as a template. These fragments were ligated into the unique EcoRV restriction site of pREV6 to yield pORF3PEX, pVirRT, and p004, respectively. An intact virR gene was amplified from pBlueRegP1 by using oligonucleotides 005R and Orf3BlnI. The resulting 1,717-bp product was digested with BlnI, and the 1,296-bp fragment was cloned into SpeI-digested pVirRT.
pInterVir was constructed by amplifying a 459-bp fragment containing the orf3-virR intergenic region from pBlueRegP1, using oligonucleotides GM-Lys-F and GM-Lys-R; this fragment was subsequently ligated into EcoRV-digested pBluescript II KS. pCodingVir was constructed by amplifying an 846-bp fragment containing the virR coding region, using oligonucleotides VirRT1 and 7050REV; this fragment was subsequently ligated into EcoRV-digested pBluescript II KS. The sequences of the oligonucleotides used in the construction of these plasmids are listed in Table 2.
|
View this table: [in a new window] |
TABLE 2. Oligonucleotides used in this study
|
RNA isolation and real-time RT-PCR. RNAs were isolated from R. equi as described previously (28). Reverse transcriptase (RT) reactions using random primers (Promega) were performed with 1 U Improm II RT following the manufacturer's recommendations, with 100 ng of total RNA as the template in a final volume of 20 µl. The product was subsequently amplified using a QuantiTect SYBR green real-time kit following the manufacturer's instructions (QIAGEN). Reaction mixtures were subjected to 40 cycles of 95°C for 15 s, 60°C for 30 s, and 72°C for 30 s in a LightCycler instrument (Roche) with a temperature transition rate of 20°C/s. Melting curve analysis was performed at 50 to 95°C (temperature transition rate, 0.2°C/s), with stepwise fluorescence detection following amplification. Cycle threshold (CT) values were obtained and used to calculate the number of RNA copies per µg of total RNA, using a standard curve of known amounts of DNA target with r2 coefficients of >0.997 in the range of 5 x 103 to 5 x 108 molecules per reaction. gyrB mRNA was used as a housekeeping gene to compare the amounts of RNA in each reaction. The data reported in this paper represent the results of three independent experiments in which each sample was analyzed in duplicate. The sequences of oligonucleotides used for real-time PCR are listed in Table 2.
Fluorescent primer extension and DNA sequencing. The D4-labeled oligonucleotides D4-VIR5022 and D4-2IntPex5564 (Table 2), complementary to sequences 62 to 80 bp and 624 to 643 bp, respectively, downstream of the initiation codon of virR, were used in primer extension reactions to determine the transcriptional start sites of the virR operon. Total RNA (2 µg) and 1 µM of D4-VIR5022 were incubated at 70°C for 5 min, followed by reverse transcription at 42°C for 60 min, using 5 U of Superscript III RT in a volume of 20 µl as recommended by the manufacturer (Invitrogen). After treatment of the sample with 20 µg of RNase A at 37°C for 30 min, cDNA was precipitated and dissolved in 12 µl of nuclease-free water. The primer extension product (0.5 ng) was combined with 0.5 µl of DNA size standard kit 600 (Beckman Coulter) and 40 µl of CEQ sample loading solution (Beckman Coulter) and analyzed with a CEQ 8000 fragment analysis system on a CEQ 8000 DNA sequencer (Beckman Coulter). In addition, dideoxy sequencing reactions using either VIR5022 or 2IntPex5564 (Table 2) and 60 ng of NheI-digested pORF3PEX (Table 1) were performed using a CEQ DCTS kit as described by the manufacturer (Beckman Coulter). The D4-labeled primer extension products (50 pg) were added to the sample prior to analyzing the sequence on a CEQ 8000 DNA sequencer to identify transcriptional start sites.
mRNA half-life determination. RNAs were isolated from R. equi in the mid-logarithmic phase of growth (optical density at 600 nm = 0.5) at selected intervals following inhibition of transcription by the addition of 200 µg ml1 rifampin (Sigma). The number of mRNA copies was determined using real-time RT-PCR, followed by linear regression to determine the half-life. 16S rRNA was used for internal normalization in this study.
EMSA.
Expression and purification of virR-his were done as previously described (28). A DNA fragment containing the virR promoter region, pInterVir, was digested with EcoRI and HindIII and labeled with [
-32P]dATP, using Klenow DNA polymerase as described previously (28). The labeled fragment was subsequently purified using a QIAquick PCR purification kit according to the manufacturer's instructions (QIAGEN). Radiolabeled DNA fragments (2 ng) were incubated with purified VirR-His at 30°C for 30 min in electrophoretic mobility shift assay (EMSA) binding buffer, 20 µg of bovine serum albumin, and 1 µg of poly(dI-dC) DNA (Amersham Biosciences) in a volume of 20 µl. The samples were separated by electrophoresis in a prerun 5% nondenaturing polyacrylamide gel containing TBE (45 mM Tris base, 45 mM boric acid, 1 mM EDTA) and run at 4°C and 10 V cm1. Following drying, the gel was analyzed by autoradiography.
DNA restriction protection assay. A 459-bp fragment containing the virR promoter region was amplified using the oligonucleotides GM-Lys-F and GM-Lys-R, with pInterVir as the template. To obtain a negative control DNA region, an 846-bp fragment was amplified using the oligonucleotides VirRT1 and 7050REV. DNA fragments (500 ng) were incubated with purified VirR-His at 30°C for 30 min in EMSA binding buffer. HincII (10 units) was added to each sample, which was further incubated at 30°C for 30 min. The samples were separated by electrophoresis and visualized using SYBR green (Sigma) per the manufacturer's instructions.
|
|
|---|
![]() View larger version (18K): [in a new window] |
FIG. 1. Regulation of virR operon gene transcription by temperature and pH. mRNAs were isolated from Rhodococcus equi cells grown under noninducing (30°C, pH 8.0) or inducing (37°C, pH 6.5) growth conditions, followed by absolute quantification of the mRNA molecules using real-time RT-PCR. Transcription levels are indicated for each gene of the virR operon (virR, orf5, vapH, orf6, orf7, and orf8) and the divergently transcribed orf3 gene following growth under noninducing (gray bars) and inducing (black bars) conditions.
|
|
View this table: [in a new window] |
TABLE 3. Transcript half-lives of genes within the virR operon
|
![]() View larger version (13K): [in a new window] |
FIG. 2. Determination of PvirR and Porf5 promoter activities by real-time RT-PCR. (A) Schematic representation of inserts in the promoter probe vector pREV6. The hairpin structure marked with a "T" represents the transcriptional terminators. Genes and their direction of transcription are indicated by black arrows. The open white box represents the t tag. The transcription level of the t tag was measured by real-time RT-PCR. (B) mRNA transcript levels of the t tag in R. equi cells harboring pORF3PEX, containing both PvirR and Porf5 (1); pVirRT, containing Porf5 (2); p004 (3); or pREV6 (4). (C) mRNA transcript levels of the t tag in R. equi cells harboring pVirRT containing only Porf5 grown at 37°C and pH 6.5 (1) or at 30°C and pH 8.0 (2) and in R. equi cells harboring pREV6 grown at 37°C and pH 6.5 (3) or 30°C and pH 8.0 (4).
|
Mapping of the transcriptional start sites of the virR operon.
To determine the transcriptional start site of the virR gene, a primer extension reaction using the fluorescently labeled oligonucleotide D4-VIR5022, complementary to the virR gene, was carried out. Using mRNA isolated from R. equi grown under inducing conditions as the template, a 133-bp DNA fragment was observed (Fig. 3A). The transcriptional start site of PvirR was subsequently determined to be an adenine located 53 bp upstream of the virR initiation codon (Fig. 3A and 4D). Interestingly, the 10 sequence (nucleotides 12 to 7 [TAGCAT]) of the PvirR promoter is strikingly similar to that of the consensus
hrdB promoter (TAGART), which is recognized by the principal sigma factor of Streptomyces coelicolor (7, 15). However, there is no clear similarity in the 35 region to the consensus
hrdB promoter (TTGACA). Using the same approach, the internal transcriptional start site of Porf5 was mapped to a guanidine 585 bp downstream of the virR initiation codon (Fig. 3B and 4D). The PvirR and Porf5 promoters do not share any obvious sequence similarity in either the 10 or 35 area.
![]() View larger version (24K): [in a new window] |
FIG. 3. Determination of transcriptional start sites of the virR operon of R. equi. Fluorescent primer extension was carried out with a Cy5-labeled primer and 5 µg of total cellular RNA extracted from R. equi cells grown under inducing conditions (37°C and pH 6.5). The upper panels show the D4-labeled primer extension products combined with DNA size standards and analyzed with a CEQ 8000 fragment analysis system. The lower panels show dideoxy sequencing reactions spiked with the D4-labeled primer extension products. The arrows indicate the transcriptional start sites where the D4-labeled cDNA and sequencing products overlapped. (A) Determination of the PvirR transcriptional start site, using D4-VIR5022. (B) Determination of the Porf5 transcriptional start site, using D4-2IntPex5564. AU, arbitrary units.
|
![]() View larger version (54K): [in a new window] |
FIG. 4. Analysis of VirR DNA binding. Various concentrations of VirR were incubated with 2 ng of radiolabeled DNA containing (A) the PvirR promoter region in a 459-bp DNA fragment or (B) the Porf5 promoter region in an 846-bp DNA fragment. The amount of protein added to each lane was as follows: lanes 1, radiolabeled DNA fragment only; lanes 2, 50 ng VirR-His; lanes 3, 100 ng VirR-His; lanes 4, 200 ng VirR-His; lanes 5, 300 ng VirR-His; and lanes 6, 400 ng VirR-His. The reaction volume was 20 µl. Protein-DNA complexes are indicated with black arrowheads. Nonbound DNA is indicated with a gray arrowhead. (C) HincII restriction protection assay. DNAs were incubated with VirR and HincII, followed by analysis of the restriction digest by gel electrophoresis. Lanes 1 to 3 contain a 459-bp DNA fragment with PvirR, and lanes 5 and 6 contain an 846-bp DNA fragment with Porf5. Lanes 1 and 5, no VirR or HincII added; lanes 2 and 6, HincII added; lanes 3 and 7, HincII and VirR added. (D) Schematic representation of the 5' end of the virR operon. Genes and the direction of transcription are indicated by black arrows. The HincII sites used in the restriction protection assay and the positions of PvirR and Porf5 are indicated above the arrows. The nucleotide sequence of the sequence upstream of virR containing the PvirR promoter is shown. The PvirR transcriptional start site is indicated (+1).
|
To further corroborate that VirR-His binds to a DNA fragment containing the PvirR promoter, a restriction enzyme protection assay was carried out. The 459-bp DNA fragment containing the orf3-virR intergenic region was incubated with VirR-His and subsequently subjected to digestion with HincII, whose recognition site is located 59 to 64 bp downstream of the PvirR transcription initiation site. While VirR-His protected this 459-bp DNA fragment from HincII digestion, it failed to prevent digestion by HincII of the adjacent 846-bp DNA fragment. These data show that the VirR binding site overlaps the HincII site downstream of PvirR within the virR coding region (Fig. 4C).
VirR is a negative regulator of the virR gene. The results of the restriction enzyme protection assay show that VirR protects a HincII site located 59 to 64 bp downstream from the PvirR transcriptional start site. This strongly suggests that VirR acts as a repressor of PvirR driving the transcription of virR. To examine this possibility, plasmids with DNA fragments containing either orf3, an intact virR gene and the 5' end of orf5 (pREV5341), or orf3 and the 5' end of virR (pREV531) were electroporated into R. equi P. Transcription of virR was subsequently analyzed by RT-PCR, using primers that amplified a virR fragment located upstream of Porf5, thus analyzing only the activity of PvirR. While transcription of virR was below the detection limit in strains harboring pREV5341 (Fig. 5, lane 2), it was clearly detectable in the absence of an intact virR gene (pREV531) (Fig. 5, lane 3).
![]() View larger version (72K): [in a new window] |
FIG. 5. Autoregulation of virR transcription. mRNAs were isolated from R. equi P harboring either pREV531 (orf3-virR') or pREV5341 (orf3-virR-orf5'). virR and gyrB transcripts were subsequently detected by RT-PCR as 200-bp amplification products. The oligonucleotides used for this experiment (Table 2) amplified a region upstream of Porf5. Lane 1, 100-bp marker; lane 2, R. equi(pREV5341) (virR); lane 3, R. equi(pREV531) (virR); lane 4, R. equi(pREV5341) (gyrB); lane 5, R. equi(pREV531) (gyrB); lanes 6 and 7, RT-PCR of gyrB genes of R. equi(pREV5341) and R. equi(pREV531), respectively, without RT.
|
orf8 does not regulate transcription of the virR operon. The orf8 gene encodes a response regulator that probably interacts with an as yet unidentified chromosomally encoded sensor kinase protein to regulate virulence plasmid gene expression. To determine whether orf8 is involved in transcriptional regulation of the virR operon, the transcription levels of orf5 were compared in the wild-type strain and an orf8 disruption mutant. The orf5 transcription level in the wild-type strain was 5.6 x 105 molecules mRNA/100 ng RNA ± 7.6 x 104 molecules mRNA/100 ng RNA, whereas this level was 4.7 x 105 molecules mRNA/100 ng RNA ± 5.6 x 104 molecules mRNA/100 ng RNA for the R. equi orf8 mutant, indicating that orf8 does not play a role in regulating transcription of the virR operon.
|
|
|---|
Many LTTRs autoregulate their expression by acting as a repressor of the LTTR-encoding gene (30). The data presented here show that in this respect, virR behaves as a typical LTTR. Inactivation of virR in a virulence plasmid-free background resulted in a dramatic increase of virR transcription, which is consistent with the notion that VirR acts as a repressor of virR transcription. This is supported by the finding that VirR binds to a site that overlaps a HincII restriction site located 59 to 64 bp downstream of PvirR within the 5' end of the virR gene, which is a typical location for a repressor binding site (8). The VirR autoregulatory circuit thus results in a constant low level of transcription of the virR operon from the PvirR promoter, independent of growth temperature and pH.
Differential mRNA stability within a polycistronic transcript has been shown to lead to vastly different mRNA levels for individual genes within an operon, resulting in differential gene expression (11, 17). This could account for the observed increase in orf5, vapH, orf7, and orf8 transcripts under inducing conditions. However, the half-life of virR mRNA (1.8 min) was the same as the average half-life of the transcripts of all five genes within the virR operon and therefore does not account for the observed differential regulation of the four genes downstream of virR in the virR operon. The observed short half-lives are typical of the majority of bacterial transcripts, as recently shown for Escherichia coli and Bacillus subtilis, where over 80% of transcripts are unstable, with half-lives of <8 min (4, 12).
Deletion analysis of the virR operon showed that in addition to the PvirR promoter, transcription of the four genes downstream of virR is also driven by a second promoter located within the virR gene. In contrast to PvirR, the activity of the Porf5 promoter is regulated by temperature and pH, resulting in a 67-fold increase in transcript levels following growth under inducing conditions compared to those obtained under noninducing growth conditions. Interestingly, the activity of the Porf5 promoter in a virulence plasmid-free R. equi strain was significantly lower than that in the presence of the virulence plasmid, suggesting that one or more components encoded by the virulence plasmid are required for full activity of Porf5. One of these components is the virR gene, as inclusion of this gene on the plasmid containing Porf5 resulted in a twofold higher activity, indicating that virR is required but not sufficient for full activity of Porf5.
The p004 plasmid contains the Porf5 promoter and its upstream region (140 nucleotides) but did not display any promoter activity, indicating that a far upstream region required for Porf5 activity had been deleted. The requirement for far upstream sequences for promoter activity has been shown for many bacterial systems, for example, Pseudomonas aeruginosa and Mycobacterium tuberculosis (22, 27). Often these involve two-component regulatory systems interacting with either
54- or
70-type RNA polymerases (6, 8). However, disruption of orf8, encoding a response regulator, had no significant effect on orf5 transcription levels, showing that it is not involved in controlling transcription of the virR operon under the experimental conditions used. This strongly suggests that genome-encoded transcriptional regulators are involved in regulating the activity of the Porf5 promoter, and therefore the expression levels of the response regulator Orf8.
The 10 regions of promoters recognized by the principal sigma factors of Streptomyces coelicolor, Mycobacterium smegmatis, and M. tuberculosis (HrdB and MysA) are highly conserved (2, 7, 15). Interestingly, the 10 regions of PvirR and the previously characterized vapA promoter (28) are highly similar to those recognized by HrdB and MysA, indicating that these promoters are recognized by the main principal sigma factor of R. equi. In contrast, the 10 and 35 sequences of PvirR and Porf5 do not share any obvious sequence similarities, strongly suggesting that these two promoters are recognized by different sigma factors. The involvement of alternative sigma factors in the regulation of virulence factor expression, as proposed here, is increasingly being observed (1, 16). The R. equi genomic sequence was recently completed (http://www.sanger.ac.uk/Projects/R_equi/), and a preliminary genome analysis revealed the presence of at least 20 potential sigma factor-encoding genes (R. J. Fahey and W. G. Meijer, unpublished results). We are currently analyzing the functions of these sigma factors.
The model that emerges from these studies is that the virR operon is transcribed at a low constitutive level under noninducing conditions from the PvirR promoter, which is most likely recognized by the principal sigma factor. The noninducing growth conditions resembled those encountered during saprophytic growth of R. equi, where expression of virulence factors is not required. The constitutive low-level transcription of the virR operon is maintained through binding of VirR to a site overlapping the virR initiation codon, resulting in an autoregulatory circuit. Following a change to inducing growth conditions, which are detected by an as yet unidentified genome-encoded signal transduction pathway, Porf5 becomes active, resulting in a significant increase of orf5, vapH, orf7, and orf8, but not virR, expression. Transcription from Porf5 is dependent on an alternative sigma factor and involves far upstream sequences. The orf8 gene encodes a response regulator which is required for virulence (26) but not for Porf5 activity, whereas the roles of orf5, orf7, and vapH in virulence are not clear. Upregulation of Porf5 activity by inducing growth conditions may act as a master switch, resulting in increased expression of the response regulator Orf8, leading to subsequent full induction of the virulence genes. The validity of this model for the regulation of virulence gene expression is currently under investigation.
This work was supported by Science Foundation Ireland under grant 02/IN.1/B203. D.A.R. was supported by a grant from the Health Research Board to W.G.M.
Published ahead of print on 11 May 2007. ![]()
Present address: Trinity Biotech PLC, One Southern Cross, IDA Business Park, Bray, County Wicklow, Ireland. ![]()
|
|
|---|
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»